The present study demonstrated that circulating level of CTRP1 in both NAFLD and NAFLD+T2DM groups were significantly higher than control group which might confirm its plausible role as an adipokine accounting for metabolic actions of adiponectin in the loss of adiponectin. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.